• Explore /
  • Poster
  • / A prospective phase II trial of pembrolizumab plus lenvatinib in advanced adrenal cortical carcinoma after failure of platinum- and mitotane-based chemotherapy (ACCOMPLISH).

A prospective phase II trial of pembrolizumab plus lenvatinib in advanced adrenal cortical carcinoma after failure of platinum- and mitotane-based chemotherapy (ACCOMPLISH).

Abstract Poster

Authors

null

Inkeun Park

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Inkeun Park , Minsuk Kwon , Kwonoh Park , Se Hoon Park , Joo-Hwan Park , Sang Joon Shin , Hyun-Jeong Shim , Tak Yun , Jae-Lyun Lee , Hyo Jin Lee , Wonyoung Choi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05036434

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr TPS3)

DOI

10.1200/JCO.2023.41.6_suppl.TPS3

Abstract #

TPS3

Poster Bd #

M14

Abstract Disclosures

Similar Posters

First Author: Katharine Andress Rowe Price

First Author: Rina Hui

First Author: Maliheh Mohamadpour

First Author: J. Randolph Hecht